Eme

Epsilon Molecular Engineering is a Japan-based private biotechnology company developing next-generation biomolecules, particularly VHH single-domain antibodies, for therapeutic, diagnostic, and research applications. The company combines its proprietary humanized synthetic VHH library, PharmaLogical® Library, with cDNA display to power its high-throughput screening platform, The Month. Epsilon positions itself as a platform-driven partner for antibody discovery against difficult targets, including those that can be challenging for conventional IgG antibodies. In addition to internal technology development, the company works through collaborations and licensing, including drug discovery partnerships with pharmaceutical companies. Its activities appear to remain largely in the discovery and preclinical stage rather than late-stage clinical development.